Skip to main content

Advertisement

SpringerLink
Log in

Desmoid tumour in familial adenomatous polyposis patients: responses to treatments

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

No guidelines for desmoid tumors (DT) management are available and DT have now become the first cause of death in FAP patients who had restorative proctocolectomy. We aimed to assess the results of the different treatments used for DT in Familial Adenomatous Polyposis (FAP) patients. All patients followed for FAP who developed a DT between 1970 and 2010 were collated. We analysed separately the history of DT according to location: mesenteric, parietal or mixed. 79 FAP patients [45 females (56 %); mean age 33.3 ± 12.5] presented 149 DT and were included; 16(20 %) had a DT diagnosed during or before first abdominal surgery and 47 (59 %) had isolated mesenteric DT. 11 patients had only surgical treatment, 17 only medical treatments, 31 had combined treatment and 20 had no treatment with spontaneous DT regression or stabilization. Overall, 80 treatment lines were administered to patients with a progression free or regression rate of 43 % (34/80). Response rates were: chemotherapy 77 % (10/13); Sulindac + tamoxifen 50 % (6/12); Tamoxifen 40 % (6/15); Imatinib 36 % (4/11); Sulindac 28 % (8/29). Among the 42 surgical procedures, an R0 resection was performed in 26 (62 %) allowing the absence of recurrence for 54 %. After a median follow-up of 81 months, 8 patients died of their DT and 6 died of other cause. Overall and DT-specific survival at 20 years were 52 and 79 %, respectively. Chemotherapy was the most efficient treatment. For intra-abdominal DT, we consider it as a first choice treatment and reserve surgery when it is impossible or when DT are life threatening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Baumert BG, Spahr MO, Von Hochstetter A, Beauvois S, Landmann C, Fridrich K, Villa S, Kirschner MJ, Storme G, Thum P, Streuli HK, Lombriser N, Maurer R, Ries G, Bleher EA, Willi A, Allemann J, Buehler U, Blessing H, Luetolf UM, Davis JB, Seifert B, Infanger M (2007) The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2:12. doi:10.1186/1748-717X-2-12

    Article  PubMed Central  PubMed  Google Scholar 

  2. Lefevre JH, Parc Y, Kerneis S, Goasguen N, Benis M, Parc R, Tiret E (2008) Risk factors for development of desmoid tumours in familial adenomatous polyposis. Br J Surg 95(9):1136–1139. doi:10.1002/bjs.6241

    Article  CAS  PubMed  Google Scholar 

  3. Shields CJ, Winter DC, Kirwan WO, Redmond HP (2001) Desmoid tumours. Eur J Surg Oncol 27(8):701–706. doi:10.1053/ejso.2001.1169

    Article  CAS  PubMed  Google Scholar 

  4. Sturt NJ, Gallagher MC, Bassett P, Philp CR, Neale KF, Tomlinson IP, Silver AR, Phillips RK (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53(12):1832–1836. doi:10.1136/gut.2004.042705

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Kasper B, Strobel P, Hohenberger P (2011) Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 16(5):682–693. doi:10.1634/theoncologist.2010-0281

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Sturt NJ, Clark SK (2006) Current ideas in desmoid tumours. Fam Cancer 5(3):275–285. doi:10.1007/s10689-005-5675-1 discussion 287-278

    Article  PubMed  Google Scholar 

  7. Nieuwenhuis MH, Lefevre JH, Bulow S, Jarvinen H, Bertario L, Kerneis S, Parc Y, Vasen HF (2011) Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 54(10):1229–1234. doi:10.1097/DCR.0b013e318227e4e8

    Article  PubMed  Google Scholar 

  8. Clark SK, Neale KF, Landgrebe JC, Phillips RK (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86(9):1185–1189. doi:10.1046/j.1365-2168.1999.01222.x

    Article  CAS  PubMed  Google Scholar 

  9. Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, Raut CP (2011) A to Z of desmoid tumors. AJR Am J Roentgenol 197(6):W1008–W1014. doi:10.2214/AJR.11.6657

    Article  PubMed  Google Scholar 

  10. Church J, Lynch C, Neary P, LaGuardia L, Elayi E (2008) A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum 51(6):897–901. doi:10.1007/s10350-008-9232-5

    Article  PubMed  Google Scholar 

  11. Latchford AR, Sturt NJ, Neale K, Rogers PA, Phillips RK (2006) A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93(10):1258–1264. doi:10.1002/bjs.5425

    Article  CAS  PubMed  Google Scholar 

  12. Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A, Pilotti S, Casali PG (2001) Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 92(5):1259–1264

    Article  CAS  PubMed  Google Scholar 

  13. Okuno SH, Edmonson JH (2003) Combination chemotherapy for desmoid tumors. Cancer 97(4):1134–1135. doi:10.1002/cncr.11189

    Article  PubMed  Google Scholar 

  14. Patel SR, Benjamin RS (2006) Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24(1):11–12. doi:10.1200/JCO.2005.03.6566

    Article  PubMed  Google Scholar 

  15. Gega M, Yanagi H, Yoshikawa R, Noda M, Ikeuchi H, Tsukamoto K, Oshima T, Fujiwara Y, Gondo N, Tamura K, Utsunomiya J, Hashimoto-Tamaoki T, Yamamura T (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24(1):102–105. doi:10.1200/JCO.2005.02.1923

    Article  CAS  PubMed  Google Scholar 

  16. de Camargo VP, Keohan ML, D’Adamo DR, Antonescu CR, Brennan MF, Singer S, Ahn LS, Maki RG (2010) Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 116(9):2258–2265. doi:10.1002/cncr.25089

    PubMed Central  PubMed  Google Scholar 

  17. Dufresne A, Bertucci F, Penel N, Le Cesne A, Bui B, Tubiana-Hulin M, Ray-Coquard I, Cupissol D, Chevreau C, Perol D, Goncalves A, Jimenez M, Bringuier PP, Blay JY (2010) Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. Br J Cancer 103(4):482–485. doi:10.1038/sj.bjc.6605783

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, Nagengast FM, van der Bijl J, van Dalsen AD, Kleibeuker JH, Dekker E, Langers AM, Vecht J, Peters FT, van Dam R, van Gemert WG, Stuifbergen WN, Schouten WR, Gelderblom H, Vasen HF (2011) Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer 104(1):37–42. doi:10.1038/sj.bjc.6605997

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Hartley JE, Church JM, Gupta S, McGannon E, Fazio VW (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47(3):334–338. doi:10.1007/s10350-003-0063-0 discussion 339–340

    Article  CAS  PubMed  Google Scholar 

  20. Hamilton L, Blackstein M, Berk T, McLeod RS, Gallinger S, Madlensky L, Cohen Z (1996) Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases. Can J Surg 39(3):247–252

    PubMed Central  CAS  PubMed  Google Scholar 

  21. Patel SR, Evans HL, Benjamin RS (1993) Combination chemotherapy in adult desmoid tumors. Cancer 72(11):3244–3247

    Article  CAS  PubMed  Google Scholar 

  22. Quintini C, Ward G, Shatnawei A, Xhaja X, Hashimoto K, Steiger E, Hammel J, Uso TD, Burke CA, Church JM (2012) Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: a single center review of 154 patients. Ann Surg 255(3):511–516. doi:10.1097/SLA.0b013e31824682d4

    Article  PubMed  Google Scholar 

  23. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33(8):639–642

    Article  CAS  PubMed  Google Scholar 

  24. Okuno S (2006) The enigma of desmoid tumors. Curr Treat Options Oncol 7(6):438–443

    Article  PubMed  Google Scholar 

  25. Speake D, Evans DG, Lalloo F, Scott NA, Hill J (2007) Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg 94(8):1009–1013. doi:10.1002/bjs.5633

    Article  CAS  PubMed  Google Scholar 

  26. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G (2004) High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100(3):612–620. doi:10.1002/cncr.11937

    Article  CAS  PubMed  Google Scholar 

  27. Tanaka K, Yoshikawa R, Yanagi H, Gega M, Fujiwara Y, Hashimoto-Tamaoki T, Hirota S, Tsujimura T, Tomita N (2008) Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. World J Surg Oncol 6:17. doi:10.1186/1477-7819-6-17

    Article  PubMed Central  PubMed  Google Scholar 

  28. Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George CR, Schroeder T, Lavery I, Oakley J (1992) Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 35(1):29–33

    Article  CAS  PubMed  Google Scholar 

  29. Leithner A, Gapp M, Radl R, Pascher A, Krippl P, Leithner K, Windhager R, Beham A (2005) Immunohistochemical analysis of desmoid tumours. J Clin Pathol 58(11):1152–1156. doi:10.1136/jcp.2005.026278

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Hong H, Nadesan P, Poon R, Alman BA (2011) Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer 104(9):1452–1458. doi:10.1038/bjc.2011.107

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH, Sarcoma Alliance for Research through C (2010) Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res 16(19):4884–4891. doi:10.1158/1078-0432.CCR-10-1177

    Article  CAS  PubMed  Google Scholar 

  32. Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D, Chabaud S, Jimenez M, Duffaud F, Piperno-Neumann S, Mignot L, Blay JY (2011) Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol 22(2):452–457. doi:10.1093/annonc/mdq341

    Article  CAS  PubMed  Google Scholar 

  33. Bertani E, Chiappa A, Testori A, Mazzarol G, Biffi R, Martella S, Pace U, Soteldo J, Vigna PD, Lembo R, Andreoni B (2009) Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature. Ann Surg Oncol 16(6):1642–1649. doi:10.1245/s10434-009-0439-z

    Article  PubMed  Google Scholar 

  34. Melis M, Zager JS, Sondak VK (2008) Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98(8):594–602. doi:10.1002/jso.21033

    Article  PubMed  Google Scholar 

  35. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB (1990) Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 14(4):335–341

    Article  CAS  PubMed  Google Scholar 

  36. Berk T, Cohen Z, McLeod RS, Stern HS (1992) Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg 35(4):393–395

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Digestive Surgery, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, Paris VI, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France

    Thibault Desurmont, Jérémie H. Lefèvre, Conor Shields, Emmanuel Tiret & Yann Parc

  2. Laboratory of Angiogenetics and Oncogenetics, Hôpital Pitié-Salpétrière (AP-HP), Université Pierre et Marie Curie, Paris VI, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France

    Chrystelle Colas

Authors
  1. Thibault Desurmont
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérémie H. Lefèvre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Conor Shields
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chrystelle Colas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emmanuel Tiret
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yann Parc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jérémie H. Lefèvre.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desurmont, T., Lefèvre, J.H., Shields, C. et al. Desmoid tumour in familial adenomatous polyposis patients: responses to treatments. Familial Cancer 14, 31–39 (2015). https://doi.org/10.1007/s10689-014-9760-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-014-9760-1

Keywords

Search

Navigation